Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Feb 22;2(1):vdz055. doi: 10.1093/noajnl/vdz055

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2020. Published by Oxford University Press, the Society for Neuro-Oncology and the European Association of Neuro-Oncology.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Fig. 1 — Low Merlin expression is associated with meningioma proliferation and poor clinical outcomes. (A) Merlin expression in meningioma patients with different mitotic activity. N = 346, *P < .05, ANOVA. (B) Decreased Merlin expression was significantly correlated with the increased pathological grade. N = 346, *P < .05, ANOVA. (C and D) Decreased Merlin is associated with worse outcome in patients with meningioma. Patients were split by median expression of Merlin over the entire meningioma data set (313 patients). Patients with lower than median expression of Merlin (n = 160) are denoted in red, and those with higher than median expression of Merlin (n=153) are in blue.